i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.
You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.
You will also receive monthly ETF model portfolio and trend trader model portfolio
Two Week FREE Trial
Terms and Conditions
Hemispherx BioPharma, Inc. (AMEX: HEB)
Current Price :
52 Week Low
52 Week High
Opinion and Analysis
Hemispherx Biopharma (HEB) Gains After FDA Accepts Resubmission Regarding Ampligen NDA
Aug 14, 2012 09:15 AM |
Hemispherx And Fountain To Start China Trial Of Flu Drug
May 26, 2010 02:55 PM |
Market Closing Update: Flat Finish For Wall Street As Energy Shares Weigh
Dec 02, 2009 04:50 PM |
More Articles on HEB..
Hemispherx' Drug Ampligen Plus Intranasal Seasonal Influenza Vaccine Induces Cross-Reactive Antibody Formation Against Avian H5N1 and H7N9 Influenza HA in Humans
Sep 15, 2014 08:30 AM |
Hemispherx Biopharma and the Swiss Department of Defense, Civil Protection and Sports Expand Their Collaborative Research Agreement to Include the Study of Alferon(R) and Ampligen(R) Against the Ebola Virus
Sep 10, 2014 08:30 AM |
Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Agree to Collaborate in Studying Alferon(R) and Ampligen(R) Against the Ebola Virus
Sep 08, 2014 08:30 AM |
More Press Releases on HEB..
Avg. Short Term
Avg. Long Term
Compare to S&P
Join Blog Network
| Copyright 2014 all rights reserved
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
. Advertisement partners
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.